Novel Biomarkers: Utility in Patients with Acute Chest Pain and Relationship to Coronary Artery Disease on Coronary CT Angiography

Current Cardiovascular Imaging Reports
Adefolakemi BabatundeQuynh A Truong

Abstract

Acute chest pain remains one of the most common patient presentations encountered in the emergency department. With the evolution of biomarkers and improvement in cardiac imaging there has been advancement in risk stratification of patients, but millions of dollars continue to be spent in the assessment of chest pain. Investigators have explored possible comparative alternatives to the traditional work up of chest pain. In this review, we will discuss the current state of biomarker use in the evaluation of acute chest pain. We will review established and emerging circulating biomarkers and their addition to cardiac CT for appropriate diagnosis of coronary artery disease.

References

Oct 31, 1996·The New England Journal of Medicine·E M OhmanE J Topol
Oct 24, 1998·JAMA : the Journal of the American Medical Association·A A PanjuD L Simel
May 16, 2000·Arteriosclerosis, Thrombosis, and Vascular Biology·R VirmaniS M Schwartz
Aug 14, 2001·Journal of the American College of Cardiology·P A HeidenreichM A Hlatky
Feb 28, 2002·Circulation·Amanda M VarnavaMichael J Davies
Jan 24, 2003·Critical Reviews in Biochemistry and Molecular Biology·Philippe E Van den SteenGhislain Opdenakker
Feb 25, 2006·The Canadian Journal of Cardiology·Peter LiuSawsan Sader
Aug 28, 2009·The New England Journal of Medicine·Till KellerStefan Blankenberg
Sep 24, 2011·Journal of the American College of Cardiology·James A GoldsteinUNKNOWN CT-STAT Investigators
Oct 4, 2011·Circulation Journal : Official Journal of the Japanese Circulation Society·Nobuaki KobayashiKyoichi Mizuno
Jan 11, 2012·International Journal of Immunopathology and Pharmacology·C FalconeG Pelissero
Mar 15, 2012·European Heart Journal·Eugene Braunwald
Mar 28, 2012·The New England Journal of Medicine·Harold I LittJudd E Hollander
Jul 27, 2012·The New England Journal of Medicine·Udo HoffmannUNKNOWN ROMICAT-II Investigators
Oct 26, 2012·The New England Journal of Medicine·Mahir Karakas, Wolfgang Koenig
Oct 26, 2012·The New England Journal of Medicine·James K MinDaniel S Berman
Mar 26, 2013·Journal of the American Heart Association·Payman ZamaniUNKNOWN Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Study Investigators
Nov 13, 2013·European Heart Journal·Richard TroughtonJames L Januzzi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biomarkers for Cardiovascular Risk Assessment

Sensitive and accurate biomarkers used in cardiovascular risk prediction can potentially be used to manage the risk of cardiovascular disease. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here.

Related Papers

Nihon rinsho. Japanese journal of clinical medicine
Mashairo JinzakiMinoru Yamada
Nihon rinsho. Japanese journal of clinical medicine
Jota Oyabu, Kinya Otsu
Emergency Radiology
Harpreet K PannuElliot K Fishman
The American Journal of the Medical Sciences
Julie J RamosStamatios Lerakis
© 2022 Meta ULC. All rights reserved